Table 1 Patient clinical characteristics
Total | |
|---|---|
Patients | 155 (100%) |
Sex | |
Male | 47 (30.3%) |
Female | 108 (69.7%) |
Age | |
Mean (SD) | 66.9 (11.4) |
Median (Min.-Max.) | 67 (37–88) |
Race | |
Caucasian | 149 (96.2%) |
Latin | 5 (3.2%) |
African | 1 (0.6%) |
Smoking habit | |
Non-smoker (≤100 cigarettes over lifetime) | 99 (63.9%) |
Former smoker (≥1 year) | 41 (26.5%) |
Smoker | 14 (9.0%) |
Not provided | 1 (0.6%) |
Performance Status (PS) | |
0 | 43 (27.7%) |
1 | 75 (48.4%) |
2 | 10 (6.5%) |
3 | 3 (1.9%) |
Not reported | 24 (15.5%) |
Histology | |
Adenocarcinoma | 154 (99.4%) |
Undifferentiated | 1 (0.6%) |
M staging | |
MX | 1 (0.6%) |
M0 | 27 (17.5%) |
M1 | 127 (81.9%) |
Metastatic sites | |
Extra-thoracic adenopathy | 16 (10.3%) |
Thoracic adenopathy | 40 (25.8%) |
Meningeal carcinomatosis | 2 (1.3%) |
Pericardial effusion | 7 (4.5%) |
Pleural effusion | 46 (29.7%) |
Liver | 19 (12.3%) |
Bones | 59 (38.1%) |
Bilateral lymphangitis | 7 (4.5%) |
Pleural nodes | 29 (18.7%) |
Peritoneal | 4 (2.6%) |
Lung | 79 (51.0%) |
Central nervous system | 22 (14.2%) |
Subcutaneous | 1 (0.6%) |
Suprarenal | 9 (5.8%) |
Soft tissue | 2 (1.3%) |
Choroids | 2 (1.3%) |